It could promote the recruitment of CD8+ T cells in the TME, and the activation of CD8+ T cells could be enhanced by increasing the proportion of DCs in the tumor and upregulating the expression of the costimulatory ligand CD86 on them.122. The gene discussed is CD8A; the disease is neoplasm.